This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics

SAVINGS DEADLINE EXPIRES:

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Delivered as Hybrid Event from 16-18 November 2022
Live In-Person Conference Delivered 16-18 NovemberAustria Center Vienna

Scott Mix
Director, Translational Research at Exicure Inc

Profile

Scott Mix is currently the Director of Translational Research at Exicure, Inc. His team is responsible for non-GMP and GMP oligonucleotide manufacturing to support nonclinical and clinical research. He received his Bachelor of Science degree from Loyola University of Maryland and his Master of Science Degree in neurobiology and physiology from Northwestern University.

Agenda Sessions

  • A Scalable Method for Endotoxin Reduction of Cholesteryl Ester-Modified Oligonucleotides

    10:30